As of 2025-07-08, the Fair Value of Allogene Therapeutics Inc (ALLO) is -5.77 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.19 USD, the upside of Allogene Therapeutics Inc is -584.70%.
With the market price of 1.19 USD and our fair value calculation, Allogene Therapeutics Inc (ALLO) is not a good investment. Investing in ALLO stocks now will result in a potential loss of 584.70%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -250.22 | -257.01 | -332.63 | -327.26 | -257.59 | -284.94 |
| YoY growth | -35.55% | -2.71% | -29.42% | 1.61% | 21.29% | -8.96% |
| Market Cap (mil) | 260.29 |
| P/E | |
| Forward P/E |
| EPS | -1.15 |
| Avg earnings growth rate | -8.96% |
| TTM earnings | -252.32 |